Lincomycin Serum and Saliva Concentrations After Intramuscular Injection of High Doses
Authors:
- 1 October 1981
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 21 (10) , 411-417
Abstract
Serum and saliva levels of lincomycin were determined in 15 normal adult male volunteers after a single intramuscular injection of 600, 1000, or 1500 mg lincomycin in a three‐way crossover study. The area under the serum concentration—time curve did not increase in proportion to the increase in dose. The increase in concentration of lincomycin in saliva was greater than expected for the increase in dose. There were no significant differences in elimination half‐life between doses. These results suggest that the apparent clearance of lincomycin increases with increasing dose possibly because of a decrease in serum protein binding of lincomycin at high serum concentrations.Keywords
This publication has 7 references indexed in Scilit:
- Lincomycin and Clindamycin1978
- Therapeutic Drug Monitoring in SalivaClinical Pharmacokinetics, 1978
- Serum Protein Binding of Erythromycin, Lincomycin, and ClindamycinJournal of Pharmaceutical Sciences, 1973
- Lineomycin Administered by Intravenous Infusion to Normal Volunteers Part I: ToleranceThe Journal of Clinical Pharmacology and New Drugs, 1971
- LINCOMYCINThe American Journal of the Medical Sciences, 1967
- Use of computers in pharmacokineticsClinical Pharmacology & Therapeutics, 1967
- MICROBIOLOGICAL, PHARMACOLOGICAL AND CLINICAL STUDIES OF LINCOMYCINThe American Journal of the Medical Sciences, 1965